Department of Virology, G, Papanikolaou Research Center of Oncology and Experimental Surgery, Regional Anticancer Oncology Hospital of Athens St, Savvas, 171 Alexandras Avenue, 11522, Athens, Greece.
BMC Infect Dis. 2013 Jan 30;13:53. doi: 10.1186/1471-2334-13-53.
A cross sectional study to investigate HPV prevalence according to age and cytology.
Women presenting to a gynaecological outpatient clinic for a Pap smear test were included in the study (n=3177). All women had cervical cytology and HPV testing.
Overall prevalence of any 24 HPV type analysed was 33.1% (95% CI 31.5% to 34.7%) and HPV 16 and HPV 42 were the most frequent (6.7% (95% CI 5.8% to 7.6%), 6.8% (95% CI 5.9% to 7.6%)), in total samples. Multiple HPV infection rate was 12.9% (95% CI 11.8% to 14.1%). High risk HPV (hrHPV) types were present in 27.4% (95% CI 25.8% to 28.9%) of the samples.HPV prevalence was highest among 14 to 19 y.o (46.6% (95% CI 40.7%-52.4%)) and second highest among 30-34 y.o. (39.7%, 95% CI 35.4%-44%). HPV 16 was highest among 20-24 (9.0% (95% CI 6.4%-11.6%)) and second highest among 50 to 54 y.o. (6.3% (95% CI 2.9% to 9.8%).In Low-grade Squamous Intraepithelial Lesions (LgSIL) cytology samples, the most frequently detected hrHPV types were: 16 (14.5% (95% CI 12.1% to 16.9%)), 51 (13.0% (95% CI 10.7% to 15.3%)) and 53 (9.1% (95% CI 7.2% to 11.1%)) and in High-grade Squamous Intraepithelial Lesions (HgSIL) were: HPV 16 (37.2% (95% CI 26.5% to 47.9%)), HPV 51 (17.9% (95% CI 9.4% to 26.5%)) and HPV 18 (12.8% (95% CI 5.4% to 20.2%)).
In the population studied, HPV 16 and 51 were the most frequent detected hrHPV types. HPV positivity, hrHPV and multiple HPV types infections were higher in young women, while HPV prevalence declined with increasing age and presented two peaks a higher (14-19 y.o.) and a lower one (30-34 y.o.) These results may contribute to the creation of a national screening programme.
本研究旨在调查 HPV 流行率与年龄和细胞学的关系。
研究纳入在妇科门诊就诊进行巴氏涂片检查的女性(n=3177)。所有女性均进行宫颈细胞学和 HPV 检测。
在所有样本中,24 种 HPV 型的总流行率为 33.1%(95%CI 31.5%至 34.7%),HPV 16 和 HPV 42 最为常见(6.7%(95%CI 5.8%至 7.6%)、6.8%(95%CI 5.9%至 7.6%))。多重 HPV 感染率为 12.9%(95%CI 11.8%至 14.1%)。高危型 HPV(hrHPV)在 27.4%的样本中存在(95%CI 25.8%至 28.9%)。HPV 感染率在 14 至 19 岁年龄组最高(46.6%(95%CI 40.7%至 52.4%)),其次是 30 至 34 岁年龄组(39.7%,95%CI 35.4%至 44%)。HPV 16 在 20 至 24 岁年龄组中最为常见(9.0%(95%CI 6.4%至 11.6%)),其次是 50 至 54 岁年龄组(6.3%(95%CI 2.9%至 9.8%))。在低级别鳞状上皮内病变(LgSIL)细胞学样本中,最常检测到的 hrHPV 类型为:16(14.5%(95%CI 12.1%至 16.9%))、51(13.0%(95%CI 10.7%至 15.3%))和 53(9.1%(95%CI 7.2%至 11.1%));在高级别鳞状上皮内病变(HgSIL)中,最常见的 HPV 类型为:HPV 16(37.2%(95%CI 26.5%至 47.9%))、HPV 51(17.9%(95%CI 9.4%至 26.5%))和 HPV 18(12.8%(95%CI 5.4%至 20.2%))。
在研究人群中,HPV 16 和 51 是最常见的高危型 HPV 类型。HPV 阳性、hrHPV 和多重 HPV 感染在年轻女性中更为常见,而 HPV 感染率随年龄增长而下降,呈双峰分布,较高的峰(14-19 岁)和较低的峰(30-34 岁)。这些结果可能有助于制定全国性的筛查计划。